Y-Mabs Therapeutics Inc - YMAB - stock price prediction, stock price target, analyst ratings from 10 analysts

Y-Mabs Therapeutics Inc has a share price target of US$ 15, revenue growth forecast of -6.0%, and profit growth estimate of -50.8% for FY25, based on top 10 analyst calls.